Global Roundup: EU Approves ViiV’s HIV-1 Drug and More
The Pharma Data
DECEMBER 23, 2020
The agreement includes a £500,000 upfront payment to Avacta which gives Astrea the rights to generate and develop Affimer reagents in-house for affinity separation. BioMedion AG – Germany-based BioMedion acquired the Compliance Division of arivis AG, a provider of regulatory software and biomedical 3D and big image data software solutions.
52 
Let's personalize your content